HCPCS Level IIdrugActive
J9030
Bcg live intravesical 1mg
BETOS: O1D
Effective: 2024-01-01
Referenced in 1 policies
Description
Bcg live intravesical instillation, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Tice Bcg
Manufacturer
Merck Sharp & Dohme LLC
HCPCS Dosage
1 MG
Billing Units
50.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.